FrancophonIA/ELRC3.0 huggingface dataset:
English: ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints) was a study designed to test the benefit of adding aliskiren to a standard therapy of an ACE-inhibitor or an angiotensin II receptor blocker in patients with type 2 diabetes mellitus and chronic kidney disease, cardiovascular disease, or both.
Maltese: ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints)
English: NAME OF THE MEDICINAL PRODUCT Ipreziv 40 mg tablets
Maltese: Ipreziv 40 mg pilloli
English: Azilsartan medoxomil is rapidly hydrolysed to the active moiety azilsartan by esterases in the gastro intestinal tract and/or during drug absorption (see section 5.2).
Maltese: Azilsartan medoxomil huwa jdorilizzat malajr għas-sustanza attiva ta' azilsartan minn esterases talapparat gastrointestinali u/jew waqt l-assorbiment tal-medicina (ara sezzjoni 5
English: Blood pressure reductions compared with placebo based on 24 hour mean blood pressure by ambulatory blood pressure monitoring (ABPM) and clinic blood pressure measurements at trough are shown in the table below for both studies.
Maltese: Tnaqqis fil- pressjoni tad-demm mqabbel ma' placebo bbażat fuq 24 siegħa ta' pressjoni tad demm medja permezz ta' treġija ambulatorju tal-pressjoni tad-demm (ABPM) u pressjoni tad-demm klinika bil-qieghda huma murija fit-tabella hawn taħt.
English: For patients with possible depletion of intravascular volume or salt depletion (e.g. patients with vomiting, diarrhoea or taking high doses of diuretics), Ipreziv should be initiated under close medical supervision and consideration can be given to 20 mg as a starting dose (see section 4.4).
Maltese: Għal pazjenti bi tnaqqis possibbli fil-volum intravaskulari jew tnaqqis fil-melħ (eż. pazjenti b'rimettar, dijarea jew li jieħdu dożi għolja ta' dijuretiċi), Ipreziv għandu jinbeda taħt superviżjoni medika stretta u konsiderazzjoni tista' tingħata sa 20 mg bħala doża tal-bidu (ara 4.4 ).
English: Other medicines and Ipreziv
Maltese: Mediċini oħra u Ipreziv
English: Marketing Authorisation Holder:
Maltese: Id-Detentur ta' l-Awtorizzazzjoni għat-tqegħid fis-Suq:
English: (medicines to relieve pain and inflammation) - Aspirin (acetylsalicyclic acid) if taking more than 3 g per day (medicine to relieve pain and
Maltese: (mediċini biex itaffu l-uġigħ u infjammazzjoni) - Aspirina (aċidu aċetilsaliċikliku) jekk tieħu' aktar minn 3 g kuljum (mediċina biex ittaffi l-uġigħ
English: Swelling of the hands, ankles or feet is more common (in less than 1 in 10 users) when Ipreziv is taken with amlodipine (a calcium channel blocker for treating hypertension) than when Ipreziv is taken alone (less than 1 in 100 users).
Maltese: Nefħa tal-idejn, għekiesi jew saqajn huma aktar komuni (f'inqas minn 1 minn kull 10 utenti) meta Ipreziv jittieħed ma' amlodipine (imblokkatur tal-kanali tal-kalċju għal kura ta' ipertensjoni) milli meta Ipreziv huwa meħud waħdu (inqas minn 1 f'kull 100 utenti).
English: NAME OF THE MEDICINAL PRODUCT Ipreziv 40 mg tablets azilsartan medoxomil
Maltese: Ipreziv 40 mg pilloli azilsartan medoxomil
English: Musculoskeletal and connective tissue disorders General disorders and administration site conditions
Maltese: Disturbi muskolu-skeletriċi u tat-tessuti konnettivi
English: Placebo at 0.05 level within the framework of the step-wise analysis † Significant difference vs. Comparator(s) at 0.05 level within the framework of the step-wise analysis # Maximum dose achieved in study 2.
Maltese: Plaċebo f'livell ta' 0.05 fil-qafas tal-analiżi ta' pass-għaqli
English: NAME OF THE MEDICINAL PRODUCT Ipreziv 20 mg tablets
Maltese: Ipreziv 20 mg pilloli
English: Coadministration of Ipreziv with diuretics, such as chlortalidone, resulted in a greater incidence of creatinine elevations, an observation consistent with that of other angiotensin II receptor antagonists and angiotensin converting enzyme inhibitors.
Maltese: L-għoti ta' Ipreziv flimkien ma' dijuretiċi, bħal klortalidon, wasslet għal inċidenza akbar ta' żiediet ta' krejatinina, osservazzjoni konsistenti ma' dik ta' antagonisti oħra tar-riċetturi anġjotensina II u inibituri tal-enżimi li jikkonvertu anġjotensina.
English: In particular, tell your doctor if you are taking any of the following medicines: - Lithium (a medicine for mental health problems) - Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, diclofenac or celecoxib
Maltese: - Mediċini anti-infjammatorji mhux sterojdi (NSAIDs), bħal ibuprofen, diclofenac jew celecoxib
English: Pack sizes: One blister pack contains either14 tablets or 15 tablets.
Maltese: Pakkett ta' folja waħda fih 14-il pillola jew 15-il pillola.
English: - have severe liver disease - have heart problems (including heart failure, recent heart attack) - have ever had a stroke - have low blood pressure or feel dizzy or lightheaded - are vomiting, have recently had severe vomiting, or have diarrhoea - have elevated levels of potassium in your blood - have a disease of the adrenal gland called primary hyperaldosteronism - have been told that you have a narrowing of the valves in your heart (called “aortic or mitral valve stenosis”) or that the thickness of your heart muscle is abnormally increased (called
Maltese: - għandek pressjoni baxxa jew tħoss rasek iddur bik jew sturdut - qed tirrimetti, riċentement kellek rimettar sever, jew għandek dijarea - għandek livelli elevati tal-potassju fid-demm - għandek mard tal-glandola adrenali msejħa iperaldosteroniżmu primarja - qalulek li għandek tidjiq tal-valvoli ta' qalbek (imsejħa "stenosi aortika jew tal-valv mitrali")
English: NAME OF THE MEDICINAL PRODUCT Ipreziv 80 mg tablets
Maltese: Ipreziv 80 mg pilloli
English: In the repeated-dose toxicity studies, doses producing exposure comparable to that in the clinical therapeutic range caused reduced red cell parameters, changes in the kidney and renal haemodynamics, as well as increased serum potassium in normotensive animals.
Maltese: Fl-istudji ta' tossiċità b'dożi ripetuti, id-dożi li jipproduċu espożizzjoni komparabbli ma' dik fil-medda terapewtika klinika ikkawżaw nuqqas fil-parametri taċ-ċelluli ħomor, bidliet fl-emodinamiċi tal-kliewi u renali, kif ukoll żieda fil-potassju fis-serum fl-annimali b'pressjoni normali.
English: NAME OF THE MEDICINAL PRODUCT Ipreziv 20 mg tablets azilsartan medoxomil
Maltese: Ipreziv 20 mg pilloli azilsartan medoxomil
English: White to nearly white round tablets, 7.6 mm in diameter, debossed “ASL” on one side and “40” on the other.
Maltese: Pilloli bojod għal kważi bojod tondi, b'dijametru ta' 7.6 mm, b' “ASL” debuzzat fuq naħa waħda u
English: Patients with primary hyperaldosteronism generally will not respond to antihypertensive medicinal products acting through inhibition of the renin-angiotensin system.
Maltese: Pazjenti b'iperaldosteroniżmu primarju ġeneralment mhux ser jirrispondi għal prodotti mediċinali antiipertensivi li jaġixxu permezz ta' inibizzjoni tas-sistema renin-anġjotensina.
English: Fumaric acid (E 297) Sodium hydroxide Hydroxypropylcellulose (E 463) Croscarmellose sodium Cellulose, microcrystalline (E 460) Magnesium stearate (E 572)
Maltese: Ċellulosi, mikrokristallina (E 460)
English: When pregnancy is diagnosed, treatment with angiotensin II receptor antagonists should be stopped immediately, and, if appropriate, alternative therapy should be started (see sections 4.3 and 4.6).
Maltese: Meta t tqala tkun iddijanjostikata, il-kura b'antagonisti tar-riċetturi ta' angiotensin II għandha titwaqqaf immedjatament, u, jekk ikun xieraq, għandha tinbeda kura alternattiva (ara sezzjonijiet 4.3 u 4.6).
English: Rebound hypertension was not observed following abrupt cessation of Ipreziv therapy after 6 months of treatment.
Maltese: Ma kienx osservat ritorn ta' ipertensjoni wara waqfien f'daqqa tat-terapija b'Ipreziv wara 6 xhur ta' kura.
English: Hemoglobin and hematocrit
Maltese: IL-PRODOTTI MEDIĊINALI, JEKK HEMM BŻONN
English: Characteristics in specific groups of patients
Maltese: Karatteristiċi fi gruppi speċifiċi ta' pazjenti
English: As with other angiotensin II receptor antagonists the combination of lithium and Ipreziv is not recommended (see section 4.5).
Maltese: L-użu ta' antagonisti tar-riċetturi ta' angiotensin II mhuwiex rakkomandat matul l-ewwel trimestru tat tqala (ara sezzjoni 4.4).
English: In these clinical studies, adverse reactions associated with treatment with Ipreziv were mostly mild or moderate, with an overall incidence similar to placebo.
Maltese: F'dawn l-istudji kliniċi, reazzjonijiet avversi assoċjati mal-kura b'Ipreziv kienu l-aktar ħfief jew moderati, b'inċidenza globali simili għal plaċebo.
English: Luxembourg/Luxemburg Takeda Belgium Tél/Tel: +32 2 464 06 11 takeda-belgium@takeda.com
Maltese: Luxembourg/Luxemburg Takeda Belgium Tél/Tel:
English: NAME OF THE MEDICINAL PRODUCT Ipreziv 80 mg tablets azilsartan medoxomil
Maltese: Ipreziv 80 mg pilloli azilsartan medoxomil
English: Common
Maltese: JIS
English: ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints) was a study designed to test the benefit of adding aliskiren to a standard therapy of an ACE inhibitor or an angiotensin II receptor blocker in patients with type 2 diabetes mellitus and chronic kidney disease, cardiovascular disease, or both.
Maltese: kien studju maħsub biex jittestja l-benefiċċju li jiżdied aliskiren ma' terapija standard ta' inibitur ta' ACE jew imblokkatur tar-riċetturi ta' angiotensin II f'pazjenti b'dijabete mellitus tip 2 u mard kroniku tal-kliewi, mard kardjovaskulari, jew it-tnejn.
English: White to nearly white round tablets, 6.0 mm in diameter, debossed “ASL” on one side and “20” on the other.
Maltese: Pilloli bojod għal kważi bojod tondi, b'dijametru ta' 6.0 mm, b' “ASL” debuzzat fuq naħa waħda u
English: Additionally, Ipreziv 80 mg resulted in significantly greater reductions in SBP than the highest approved doses of olmesartan medoxomil and valsartan.
Maltese: Barra minn hekk, 80 mg ta' Ipreziv irriżulta f'tnaqqis akbar b'mod sinifikanti fl-SPB minn dożi għolja approvati ta' medoxomil olmesartan u valsartan.
English: INFORMATION IN BRAILLE Ipreziv 40 mg
Maltese: Ipreziv 40 mg
English: There was no evidence of QT/QTc prolongation at a dose of 320 mg of Ipreziv.
Maltese: Ma kienx hemm evidenza ta' QT/QTc b'doża ta' 320 mg ta' Ipreziv.
English: Your doctor will normally advise you to stop taking Ipreziv before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Ipreziv.
Maltese: Rappurtar ta' reazzjonijiet avversi suspettati Huwa importanti li jiġu rrappurtati reazzjonijiet avversi suspettati wara l-awtorizzazzjoni tal-prodott mediċinali.
English: Caution should be exercised in hypertensive patients with severe renal impairment and end stage renal disease as there is no experience of use of Ipreziv in these patients (see sections 4.4 and 5.2).
Maltese: Ipreziv ma ġiex studjat f'pazjenti b'indeboliment epatiku serju u għalhekk l-użu tiegħu mhux rakkomandat f'dan il-grupp ta' pazjenti (ara sezzjonijiet 4.4 u 5.2).
English: EXPIRY DATE
Maltese: Dijarea Dardir
English: Aortic and mitral valve stenosis, obstructive hypertrophic cardiomyopathy Special caution is indicated in patients suffering from aortic or mitral valve stenosis, or hypertrophic obstructive cardiomyopathy (HOCM).
Maltese: Aqra sew dan il-fuljett kollu qabel tibda tieħu din il-mediċina peress li fih informazzjoni importanti għalik.
English: Cardiovascular death and stroke were both numerically more frequent in the aliskiren group than in the placebo group and adverse events and serious adverse events of interest (hyperkalaemia, hypotension and renal dysfunction) were more frequently reported in the aliskiren group than in the placebo group.
Maltese: Mewt kardjovaskulari u puplesija t-tnejn kienu numerikament iktar frekwenti fil grupp ta' aliskiren milli fil-grupp tal-plaċebo, u avvenimenti avversi u avvenimenti avversi serji ta'
English: Ipreziv contains an active substance called azilsartan medoxomil and belongs to a class of medicines called angiotensin II receptor antagonists (AIIRAs).
Maltese: Informazzjoni addizzjonali Dejta minn provi kliniċi wriet li imblokk doppju tas-sistema renin-angiotensin-aldosterone (RAAS)
English: Caution should be exercised in hypertensive patients with severe renal impairment, congestive heart failure or renal artery stenosis, as there is no experience of use of Ipreziv in these patients (see sections 4.2 and 5.2).
Maltese: Għandu jkun hemm kawtela f'pazjenti bi pressjoni għolja b'indeboliment renali serju, b'insuffiċjenza tal-qalb jew stenosi arterja tal-kliewi, hekk kif hemm esperjenza limitata ta' użu b'Ipreziv f'dawn ilpazjenti (ara sezzjonijiet 4.2 u 5.2).
English: The full EPAR for Somatropin Biopartners can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: L-EPAR sħiħ għal Somatropin Biopartners jinstab fis-sit elettroniku tal-Aġenzija: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Somatropin Biopartners on 05.08.2013.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Somatropin Biopartners fil- 05.08.2013.
English: This summary was last updated in 07-2013.
Maltese: Is-sommarju ġie aġġornat l-aħħar fi 07-2013.
English: The active substance in Somatropin Biopartners, somatropin, is identical to the human growth hormone.
Maltese: Is-sustanza attiva f'Somatropin Biopartners, somatropin, hija identika għall-ormon tat-tkabbir uman.
English: In children, the recommended dose is 0.5 mg per kilogram body weight, injected once a week.
Maltese: Fittfal, id-doża rakkomandata hija ta' 0.5 mg għal kull kilogramm tal-piż tal-ġisem, li tiġi injettata darba fil-ġimgħa.
English: Other information about Somatropin Biopartners
Maltese: Informazzjoni oħra dwar Somatropin Biopartners
English: This is a summary of the European public assessment report (EPAR) for Somatropin Biopartners.
Maltese: Dan huwa sommarju tar-Rapport Pubbliku Ewropew ta' Valutazzjoni (EPAR) għal Somatropin Biopartners.
English: Somatropin Biopartners is a medicine that contains human growth hormone (also known as somatropin).
Maltese: Somatropin Biopartners huwa mediċina li fiha l-ormon tat-tkabbir uman (magħruf ukoll bħala somatropin).
English: The study showed that Somatropin Biopartners was as effective as Genotropin at promoting growth: children receiving Somatropin Biopartners grew around 11.7 cm in one year, compared with 12.0 cm in children receiving Genotropin.
Maltese: L-istudju wera li Somatropin Biopartners kien effettiv daqs Genotropin fil-promozzjoni tat-tkabbir: it-tfal li kienu qed jirċievu Somatropin Biopartners kibru madwar 11.7 cm f'sena, meta mqabbla ma' 12.0 cm fit-tfal li kienu qed jirċievu Genotropin.
English: It is produced by a method known as ‘recombinant DNA technology': the hormone is made by yeast cells into which a gene (DNA) has been introduced that makes them able to produce it. Somatropin Biopartners replaces the natural hormone.
Maltese: Tiġi prodotta b'metodu magħruf bħala ‘teknoloġija rikombinanti tad-DNA': l-ormon jiġi magħmul minn ċelloli tal-ħmira li fihom ikun ġie introdott ġene (DNA) li jagħmilhom kapaċi jirriproduċuh.
English: Somatropin Biopartners has also been studied in one main study involving 151 adults with growth hormone deficiency.
Maltese: Somatropin Biopartners ġie studjat ukoll fi studju ewlieni wieħed li fih ħadu sehem 151 adult biddefiċjenza tal-ormon tat-tkabbir.
English: A risk management plan has been developed to ensure that Somatropin Biopartners is used as safely as possible.
Maltese: Ġie żviluppat pjan ta' ġestjoni tar-riskju biex jassigura li Somatropin Biopartners jintuża bl-aktar mod sigur possibbli.
English: In children, the most common side effects with Somatropin Biopartners (which may affect more than 1 in 10 people) are injection site swelling and development of antibodies (proteins that are produced in response to Somatropin Biopartners).
Maltese: Fit-tfal, l-effetti sekondarji l-aktar komuni b'Somatropin Biopartners (li jistgħu jolqtu aktar minn 1 minn kull 10 persuni) huma nefħa fis-sit tal-injezzjoni u l-iżvilupp ta' antikorpi (proteini prodotti bħala rispons għal Somatropin Biopartners).
English: In adults, the most common side effects (which may affect more than 1 in 10 people) are swelling, mild hyperglycaemia (high blood sugar levels) and headache.
Maltese: Fl-adulti, l-effetti sekondarji l-aktar komuni (li jistgħu jolqtu aktar minn 1 minn kull 10 persuni) huma nefħa, ipergliċemija ħafifa (livelli għolja ta' zokkor fid-demm) u uġigħ ta' ras.
English: Somatropin Biopartners is available as a powder and solvent which are made into a suspension for injection.
Maltese: Somatropin Biopartners huwa disponibbli bħala trab u solvent li jiġu magħmula f'suspensjoni għallinjezzjoni.
English: Adults treated with Somatropin Biopartners had an average reduction of body fat of 1 kg while body fat in those treated with placebo increased by 0.5 kg.
Maltese: L-adulti li rċevew kura b'Somatropin Biopartners kellhom tnaqqis medju ta' 1 kg fix-xaħam tal-ġisem filwaqt li x-xaħam fil-ġisem f'dawk li rċevew kura bi plaċebo żdied b'0.5 kg.
English: Somatropin Biopartners has been studied in one main study involving 180 children with a lack of growth hormone.
Maltese: Somatropin Biopartners ġie studjat fi studju ewlieni wieħed li fih ħadu sehem 180 tifel u tifla b'nuqqas tal-ormon tat-tkabbir.
English: Growth hormone is a substance secreted by the pituitary gland (a gland located at the base of the brain).
Maltese: L-ormon tat-tkabbir huwa sustanza li tiġi mnixxija mill-glandola pitwitarja (glandola li tinsab fin-naħa t'isfel tal-moħħ).
English: This study compared Somatropin Biopartners with placebo (a dummy treatment) and measured the decrease in body fat (which is normally high in adults with growth hormone deficiency) after 6 months of treatment.
Maltese: Dan l-istudju qabbel Somatropin Biopartners ma' plaċebo (kura finta) u kejjel it-tnaqqis tax-xaħam fil-ġisem (li normalment ikun għoli f'adulti bid-defiċjenza tal-ormon tattkabbir) wara 6 xhur ta' kura.
English: Somatropin Biopartners somatropin
Maltese: Kif jintuża Somatropin Biopartners?
English: What are the risks associated with Somatropin Biopartners?
Maltese: X'inhuma r-riskji assoċjati ma' Somatropin Biopartners?
English: In adults, the recommended dose is 2 mg injected once a week, except for female patients also taking oral oestrogen who should receive 3 mg once a week.
Maltese: Fl-adulti, id-doża rakkomandata hija ta' 2 mg li tiġi injettata darba fil-ġimgħa, ħlief għallpazjenti nisa li jkunu qed jieħdu wkoll estroġenu orali, li dawn għandhom jirċievu 3 mg darba fil ġimgħa.
English: Why is Somatropin Biopartners approved?
Maltese: Għal xiex ġie approvat Somatropin Biopartners?
English: Regarding its safety, the side effects reported with Somatropin Biopartners were similar to those of other daily somatropin medicines, with the exception of increased injection site reactions in children, which should be balanced against the convenience of weekly injections.
Maltese: Fir-rigward tas-sigurtà tiegħu, leffetti sekondarji rrapportati b'Somatropin Biopartners kienu simili għal dawk ta' mediċini oħra ta' somatropin li jittieħdu kuljum, bl-eċċezzjoni ta' żieda fir-reazzjonijiet fis-sit tal-injezzjoni fit-tfal, li għandhom jiġu bilanċjati kontra l-konvenjenza tal-injezzjonijiet darba fil-ġimgħa.
English: In adults who lack growth hormone, Somatropin Biopartners has a modest effect in decreasing body fat.
Maltese: Fl-adulti li għandhom nuqqas tal-ormon tat-tkabbir, Somatropin Biopartners għandu effett modest fit-tnaqqis tax-xaħam fil-ġisem.
English: Treatment with Somatropin Biopartners should be started and monitored by a doctor experienced in diagnosing and treating patients with growth hormone deficiency.
Maltese: Il-kura b'Somatropin Biopartners għandha tinbeda u tiġi mmonitorjata minn tabib bl-esperjenza fiddijanjosi u l-kura ta' pazjenti bid-defiċjenza tal-ormon tat-tkabbir.
English: The patient or caregiver can inject Somatropin Biopartners themselves, after training by a doctor or a nurse.
Maltese: Barra minn hekk, il-kumpanija li tqiegħed Somatropin Biopartners fis-suq se tipprovdi aktar dejta fit-tul dwar l-effikaċja u s-sigurtà tal-mediċina.
English: It promotes growth during childhood and adolescence, and also affects the way the body handles proteins, fat and carbohydrates.
Maltese: Huwa jippromwovi t-tkabbir matul it-tfulija u l-adolexxenza, u jaffettwa wkoll il-mod kif il-ġisem jimmaniġġja l-proteini, ix-xaħmijiet u l-karboidrati.
English: EPAR summary for the public
Maltese: Sommarju tal-EPAR għall-pubbliku somatropin
English: For the full list of all side effects reported with Somatropin Biopartners, see the package leaflet.
Maltese: Għallista sħiħa tal-effetti sekondarji kollha rrappurtati b'Somatropin Biopartners, ara l-fuljett ta' tagħrif.
English: - The active substance is retapamulin.
Maltese: - Is-sustanza attiva hi retapamulin.
English: Sensitisation or severe local irritation
Maltese: Sensitizzazzjoni jew irritazzjoni lokali severa
English: S. pyogenes
Maltese: SIOW bi S. pyogenes.
English: S. aureus (all) MRSA
Maltese: S. aureus (kollha)
English: Glaxo Operations UK, Ltd, (trading as Glaxo Wellcome Operations)
Maltese: Glaxo Operations UK, Ltd, (trading bħala Glaxo Wellcome Operations)
English: Date of first authorisation: 24 May 2007 Date of latest renewal: 20 April 2012
Maltese: Data tal-aħħar tiġdid: 20 ta' April 2012
English: Butylated hydroxytoluene (E321)
Maltese: Altargo fih butylated hydroxytoluene (E321)
English: EU/1/07/390/001 EU/1/07/390/002 EU/1/07/390/003 EU/1/07/390/004
Maltese: EU/1/07/390/003
English: Adults (aged 18-65 years), adolescents (aged 12-17 years), infants and children (aged from nine
Maltese: Adulti (bejn it-18 u l-65 sena), adolexxenti (bejn it-12 u s-17-il sena), trabi u tfal (minn 9 xhur sa ħdax-il
English: Glaxo Operations UK Ltd. (trdg as Glaxo Wellcome Operations) Harmire Road
Maltese: (trdg as Glaxo Wellcome Operations) Harmire Road
English: The following convention has been used for the classification of frequency: very common (>1/10), common (>1/100 to <1/10), uncommon (>1/1000 to <1/100), rare (>1/10,000 to <1/1000), very rare (<1/10,000), not known (cannot be estimated from the available
Maltese: Il-metodu li ġej intuża għall-klassifika ta' frekwenzi:komuni ħafna (>1/10), komuni (>1/100 sa <1/10), mhux komuni >1/1000 sa <1/100), rari (>1/10,000 sa <1/1000), rari ħafna (<1/10,000),mhux magħruf (ma jistax
English: * Activity has been satisfactorily demonstrated in clinical studies
Maltese: *ġiet osservata attivita` sodisfaċenti fi studji kliniċi.
English: Each gram of ointment contains up to 20 micrograms of butylated hydroxytoluene (E321).
Maltese: Kull gramma ta' ingwent fiha sa 20 mikrogramma ta' butylated hydroxytoluene (E321).
English: GlaxoSmithKline AS Tlf: + 47 22 70 20 00 firmapost@gsk.no
Maltese: GlaxoSmithKline AS Tlf: + 47 22 70 20 00 firmapost@gsk.no Österreich
English: Contact dermatitis
Maltese: Dermatite minn kuntatt
English: GlaxoSmithKline (Malta) Limited Tel: + 356 21 238131
Maltese: GlaxoSmithKline Malta(Malta) Limited Tel: + 356 21 238131
English: Retapamulin is a semi-synthetic derivative of the compound pleuromutilin, which is isolated through fermentation from Clitopilus passeckerianus (formerly Pleurotus passeckerianus).
Maltese: Retapamulin hu derivattiv semi-sintetiku tal-kompost plewromutilin, li jiġi iżolat permezz ta' fermentazzjoni mill- Clitopilus passeckerianus (li qabel kien Pleurotus passeckerianus).
English: Cephalexin n/N Success
Maltese: Plaċebo n/N Rata ta'
English: $: the response rate for MRSA due to PVL+ MRSA was 8/13 (62%)
Maltese: MRSA kkawżata minn PVL+ MRSA kienet ta' 8/13 (62%)